Given the proposed acquisition of Shockwave Medical by Johnson & Johnson, Shockwave Medical is withdrawing its full year 2024 guidance, previously issued on February 15, 2024.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
334.8 USD | -0.01% | +0.01% | +75.69% |
03/06 | Shockwave Medical, Inc.(NasdaqGS:SWAV) dropped from S&P 1000 | CI |
03/06 | Shockwave Medical, Inc.(NasdaqGS:SWAV) dropped from S&P 400 Health Care | CI |
1st Jan change | Capi. | |
---|---|---|
+75.69% | 1.26TCr | |
+12.09% | 699.99Cr | |
-30.85% | 677.69Cr | |
+9.17% | 520.31Cr | |
-20.22% | 467.11Cr | |
+16.71% | 426.33Cr | |
-21.04% | 383.97Cr | |
-27.63% | 270.28Cr | |
-0.99% | 197.69Cr | |
+17.62% | 195.42Cr |
- Stock Market
- Equities
- SWAV Stock
- News Shockwave Medical
- Shockwave Medical Withdraws Earnings Guidance for the Full Year 2024